Skip to main navigation
  • Back to SpringWorksTx.com
  • Investors & Media
  • Contact Us
  • Linkedin
  • Twitter
SpringWorks
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Corporate Governance
  • Financial Information
    • SEC Filings
    • Annual Reports
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Resources
    • Investor FAQs
    • Investor Contacts
    • Email Alerts
  • Investors + Media
  • Medical Professionals
  • Contact Us
  • Linkedin
  • Twitter

Corporate Governance

Committee Charters

Audit Committee Charter
Compensation Committee Charter
Nominating and Corporate Governance Committee Charter
Research and Development Committee Charter

Governance Documents

Code of Business Conduct & Ethics
Corporate Governance Guidelines
Director Conflict of Interest Policy

Committee Composition

Audit Committee Compensation Committee Nominating and Corporate Governance Committee Research and Development Committee
Daniel S. Lynch Compensation Committee
Carlos Alban Compensation Committee Nominating and Corporate Governance Committee
Alan Fuhrman Audit Committee Nominating and Corporate Governance Committee
Julie Hambleton, M.D. Audit Committee Research and Development Committee
Freda Lewis-Hall, M.D., DFAPA Nominating and Corporate Governance Committee
Jeffrey Schwartz Audit Committee Compensation Committee
= Chairperson = Member = Chairman of the Board

Springworks - Toolkits

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Investor Contacts

Springworks Logo

Social Links

  • linkedin
  • twitter
Footer 1
  • Who We Are
    • Leadership & Board
    • Mission & Values
    • Partners & Collaborators
  • Focus Areas
    • Rare Oncology
    • BCMA Combinations in Multiple Myeloma
    • Biomarker-Defined Metastatic Solid Tumors
Footer 2
  • Pipeline
    • Nirogacestat
    • Mirdametinib
    • Clinical Trials
    • Investigator-Initiated Research
  • Careers
    • View Opportunities
    • Desmoid Tumor Commercial Team
Footer 3
  • Patients
    • Desmoid Tumors
    • NF1-PN
    • Expanded Access
  • Contact
Footer 4
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Investor Resources

© 2023 SpringWorks Therapeutics. All rights reserved.

Copyright Links

  • Privacy Policy
  • Terms of Use
  • Cookie Policy